Clinical Implications of Thrombocytopenia at Cardiogenic Shock Presentation: Data from a Multicenter Registry.
CONCLUSION: Thrombocytopenia at CS presentation was associated with worse clinical findings, higher frequencies of complications, and longer stay at the intensive care unit. Also, thrombocytopenia was independently associated with increased 30-day mortality. (Clinical trial registration No. NCT02985008).
PMID: 32975059 [PubMed - in process]
Source: Yonsei Medical Journal - Category: Universities & Medical Training Authors: Lee HH, Hong SJ, Ahn CM, Yang JH, Gwon HC, Kim JS, Kim BK, Ko YG, Choi D, Hong MK, Jang Y Tags: Yonsei Med J Source Type: research
More News: Bleeding | Cardiogenic Shock | Cardiology | Clinical Trials | Gastroenterology | Heart | Intensive Care | Liver | Thrombocytopenia | Universities & Medical Training | Urology & Nephrology